AngioWaveNet vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
AngioWaveNet is designed to enhance real-time fluoroscopic angiograms during cardiac catheterization, improving vessel visualization for interventional procedures. In contrast, FFRct offers a non-invasive diagnostic analysis of coronary arteries from CCTA scans, providing 3D models and blood flow assessment to aid in diagnosing coronary artery disease and guiding treatment strategies. While both are cardiology AI tools, AngioWaveNet focuses on intra-procedural image enhancement, whereas FFRct is a pre-procedural diagnostic and planning tool.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
AngioWaveNet is designed to enhance fluoroscopic angiograms for improved vessel visualization during cardiac catheterization procedures. FFRct, on the other hand, is a non-invasive diagnostic tool that uses AI to create personalized 3D models from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease before intervention.
AngioWaveNet processes fluoroscopic angiograms to enhance vessel visibility. FFRct utilizes data from CCTA (Coronary Computed Tomography Angiography) scans to generate its 3D models and blood flow analysis.
AngioWaveNet integrates with existing Cath lab workflows and is compatible with any fluoroscopic angiography system, functioning as a DICOM endpoint. FFRct processes CCTA data via a cloud-based system (HeartFlow Network, AWS Cloud, or Virtual Private Cloud) with a local Virtual Appliance for data transfer.
AngioWaveNet provides improved visualization of blood vessels, vascular structures, and anatomical features in fluoroscopic angiograms. FFRct generates personalized 3D digital models of coronary arteries, analyzes blood flow, and identifies areas of narrowing using FFRct values to aid in diagnosing CAD and guiding treatment strategies.